June 2026 – September 2026
Cary Boyd-Shiwarski, MD, PhD // Renal-Electrolyte
The molecular and physiologic effects of calcineurin inhibitors on WNK body bimolecular condensates
R01 DK142678 First R01
Start Date: April 16, 2026
End Date: March 31, 2031
Total Annual Direct Costs: $493,776
The molecular and physiologic effects of calcineurin inhibitors on WNK body bimolecular condensates
R01 DK142678 First R01
Start Date: April 16, 2026
End Date: March 31, 2031
Total Annual Direct Costs: $493,776
Adam Brufsky, MD, PhD, and John Kirkwood, MD // Malignant Hematology and Medical Oncology
NCI NCTN-Network Lead Academic Participating Site at UPMC Hillman Cancer Center
UG1 CA233184 Competitive Renewal
Start Date: May 1, 2019
End Date: February 29, 2032
Total Annual Direct Costs: $673,753
NCI NCTN-Network Lead Academic Participating Site at UPMC Hillman Cancer Center
UG1 CA233184 Competitive Renewal
Start Date: May 1, 2019
End Date: February 29, 2032
Total Annual Direct Costs: $673,753
Internal Funding Opportunities
ASPIRE Funding
The overarching aim of Advancing Scientific Programs of Independently-funded Researchers (ASPIRE) is to support growth, diversification, and scientific impact of the research programs and grant portfolios of early-mid career investigators in the DOM. The Department supports up to $75k per year in funding for ASPIRE to facilitate subsequent R-level funding.
Details and application: dom.pitt.edu/aspire
Applications are due by 11:59pm on July 31, 2026.
Please direct any inquiries to chairoff@pitt.edu.